Search research articles
Contact Us
Filters
Showing results (341-350 of 569) with videos related to
Page
of 57
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1997
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice
W E Meijs, H J Haisma, R P Klok, et al.
Blood
|
June 25, 1998
Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapy
H J Haisma, M F Sernee, E Hooijberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 1, 1984
Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy
H J Keizer, A B Karim, K H Njo, et al.
Human Immunology
|
March 15, 2000
Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro
N Nishi, H J van der Vliet, Y Koezuka, et al.
Gene Therapy
|
January 11, 2000
Recombinant adenovirus vectors with knobless fibers for targeted gene transfer
V W van Beusechem, A L van Rijswijk, H H van Es, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1994
The release of interleukin-8 during intravenous bolus treatment with interleukin-2
J W Baars, G J Wolbink, M H Hart, et al.
British Journal of Cancer
|
July 1, 1990
Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA
D R Mans, J Retèl, J M van Maanen, et al.
Anticancer Research
|
July 1, 1993
Development, characterization and application of an antibody against 5-fluoro-2'deoxyuridine-5'monophosphate, the active metabolite of 5-fluorouracil
G J Peters, E Laurensse, H W Steinbusch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial
M T Huizing, J B Vermorken, H Rosing, et al.
Anti-Cancer Drug Design
|
August 1, 1994
Effect of suramin on adenylate cyclase and protein kinase C
R Lopez-Lopez, C H Langeveld, P E Pizao, et al.
Page
of 57
Search research articles
Search
Showing results (341-350 of 569) with videos related to
Sort By:
Page
of 57
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1997
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice
W E Meijs, H J Haisma, R P Klok, et al.
Blood
|
June 25, 1998
Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapy
H J Haisma, M F Sernee, E Hooijberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 1, 1984
Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy
H J Keizer, A B Karim, K H Njo, et al.
Human Immunology
|
March 15, 2000
Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro
N Nishi, H J van der Vliet, Y Koezuka, et al.
Gene Therapy
|
January 11, 2000
Recombinant adenovirus vectors with knobless fibers for targeted gene transfer
V W van Beusechem, A L van Rijswijk, H H van Es, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1994
The release of interleukin-8 during intravenous bolus treatment with interleukin-2
J W Baars, G J Wolbink, M H Hart, et al.
British Journal of Cancer
|
July 1, 1990
Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA
D R Mans, J Retèl, J M van Maanen, et al.
Anticancer Research
|
July 1, 1993
Development, characterization and application of an antibody against 5-fluoro-2'deoxyuridine-5'monophosphate, the active metabolite of 5-fluorouracil
G J Peters, E Laurensse, H W Steinbusch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial
M T Huizing, J B Vermorken, H Rosing, et al.
Anti-Cancer Drug Design
|
August 1, 1994
Effect of suramin on adenylate cyclase and protein kinase C
R Lopez-Lopez, C H Langeveld, P E Pizao, et al.
Page
of 57